Welcome to our dedicated page for Mustgrow Biologics news (Ticker: MGROF), a resource for investors and traders seeking the latest updates and insights on Mustgrow Biologics stock.
MustGrow Biologics Corp. (MGROF) generates frequent news and corporate updates related to its role in biological and regenerative agriculture. As a fully integrated provider of mustard-derived biocontrol and biofertility products, along with third-party crop nutrition solutions, the company issues news on product performance, commercialization progress, financing activities, and distribution partnerships.
Investors following MustGrow’s news can expect regular coverage of developments around its TerraSante™ organic biofertility product, including large-scale field trial results, registration status in U.S. states, and demand trends among U.S. commercial farming operations. The company also reports on TerraMG™, its mustard-based biopesticide platform, including registration efforts in Canada and the United States and collaborative work with partners such as Bayer AG in Europe, the Middle East, and Africa.
News releases also highlight MustGrow’s Canadian sales and distribution division, NexusBioAg, which handles third-party crop nutrition products and serves as a sales channel for the company’s proprietary technologies. Announcements may include new distribution agreements, such as the Canadian distribution of the RhizoSorb® phosphorus efficiency product, as well as commentary on seasonal sales patterns in the Canadian agriculture market.
In addition, MustGrow’s news flow includes financial and corporate updates such as quarterly operating results, private placements under the listed issuer financing exemption, lines of credit, share-based incentive grants, and outcomes of annual shareholder meetings. For investors and analysts, the MGROF news page on Stock Titan provides a consolidated view of these operational, financial, and strategic developments.
MustGrow Biologics has signed a non-binding term sheet with Univar Solutions Canada to acquire NexusBioAg. The strategic acquisition, targeted to close by December 31, 2024, includes deferred cash payment and contingent payments in 2025 and 2026. The deal would position MustGrow as a fully integrated provider of biological and regenerative agriculture solutions in Canada. NexusBioAg's sales and marketing team would bring extensive experience and industry networks to drive growth. The integration would give MustGrow access to NexusBioAg's existing sales, with new third-party product lines planned for 2025 and MustGrow's proprietary TerraMG™ launching thereafter.
MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) has provided its 2024 pipeline update, marking a significant transition from R&D to commercialization. Key highlights include:
1. TerraSante™ biofertility product: Initial sales have commenced in key U.S. states, with potential for full-scale sales ramp-up in 2025 and 2026.
2. TerraMG™ soil biopesticide: Commercialization is progressing under the Bayer agreement for Europe, Middle East, and Africa. Registration work continues in the U.S. and Canada.
3. Intellectual property portfolio has grown to 112 issued and pending patents.
4. Expiration of exclusive non-commercial agreements with NexusBioAg, Janssen PMP, and Sumitomo
The company is focusing on delivering commercialization of its products, validating efficacy through sales, and driving global expansion.
MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) has secured funding from Agriculture and Agri-Food Canada (AAFC) to explore mustard-derived ingredient opportunities in human and animal health applications. The project, conducted at AAFC's Guelph Research & Development Centre, will investigate potential uses in:
- Functional foods and nutraceuticals for improved immunity and gut health
- Natural food preservatives
- Antibiotic replacements in animal feeds
The research aims to analyze bioactive components in mustard seed for antibiotic and gut health applications, assess their efficacy against food spoilage microbes and disease pathogens, and test their antioxidant and anti-inflammatory effects. This initiative aligns with global efforts to combat antimicrobial resistance, a significant threat to human and animal health.
MustGrow has received approval from the Florida Department of Agriculture to commence sales of TerraSanteTM, an organic biofertility product in Florida. TerraSanteTM aims to enhance soil health, nutrient efficiency, and plant yields.
This registration includes the Organic OMRI Listed® certification, already held in Arizona, Idaho, Oregon, and Washington State. Florida's agriculture spans 47,300 farms and 9.7 million acres, producing a significant array of crops. MustGrow aims for further state-level registrations in the U.S.
TerraSanteTM contains plant proteins and carbohydrates, targeting soil and soil microbiome health, potentially improving nutrient availability, plant vigor, and yields with no artificial additives.
MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) has announced the grant of 1,575,398 deferred share units (DSUs) and restricted share units (RSUs) to certain directors, officers, and consultants, effective September 3, 2024. This grant is made under the company's Omnibus Equity Incentive Plan. The DSUs will vest when the holder ceases to be a director, officer, or employee of MustGrow or its affiliates. Upon settlement, each DSU will entitle the holder to receive one common share in the company's capital or an equivalent cash payment, at MustGrow's discretion.
MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) has received Arizona Department of Agriculture approval to sell TerraSante™, an organic biofertility product, in Arizona. This registration complements existing certifications in Idaho, Oregon, and Washington State. TerraSante™, derived from mustard plants, aims to enhance soil health, nutrient efficiency, and crop yields.
Arizona, with over 25 million acres of farmland, produced US$3.0 billion in agricultural crops in 2022, led by vegetables, melons, and potatoes at US$1.43 billion. The state ranks 2nd in the U.S. for various produce, including lettuce and broccoli. MustGrow's expansion into Arizona is strategic, considering many California agriculture companies use Arizona for winter farming.
MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) has received approval from the Idaho State Department of Agriculture to sell TerraSante™, an organic biofertility product, in Idaho. This registration includes organic certification under MustGrow's existing Organic OMRI Listed® certifications in Oregon and Washington State.
TerraSante™ is a mustard plant-based technology focused on improving soil and soil microbiome health, nutrient and water use efficiencies, and plant yields. It contains nutritious plant proteins and carbohydrates that feed the soil and soil microbes, potentially enhancing beneficial microbial activity and promoting long-term sustainable soil health.
Idaho is a significant agricultural state, ranking #1 in the U.S. for potatoes, barley, alfalfa hay, peppermint oil, and food trout production. The state's total agricultural crop production in 2021 was valued at US$3.3 billion, with potatoes being the top crop at US$1.3 billion in 2023.
MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) is set to promote its organic biofertility product TerraSante at the Cal Poly Strawberry Field Day on August 8, 2024. This event attracts hundreds of strawberry growers, researchers, and industry representatives from California, where strawberries represent a US$2.68 billion annual production business.
To accelerate sales efforts, MustGrow has engaged Michael Atkins, a 17-year Nutrien sales veteran and agronomist with extensive experience in Coastal California. The company recently received California Department of Food Agriculture registration approval and organic certification for TerraSante, complementing its existing certifications in Oregon and Washington State.
TerraSante focuses on soil microbiome health, nutrient and water use efficiencies, and plant yields. As an organic biofertilizer, it contains plant proteins and carbohydrates that feed soil microbes, potentially improving nutrient availability and crop performance.
MustGrow Biologics has joined the Global Alliance Against TR4, collaborating with major banana industry players such as Bayer, Chiquita, Del Monte, Dole, and Fyffes to combat Fusarium wilt TR4, a fungal disease threatening the $25 billion global banana industry.
MustGrow's mustard-derived biofungicide has shown 100% efficacy in laboratory settings and positive results in field trials, with no damage to banana plants. Under a commercial partnership, Bayer may continue developing MustGrow's technology, which aims to provide sustainable, organic crop protection solutions globally.
This alliance underscores the urgent need for innovative and sustainable solutions to ensure agricultural production's future and food security.
MustGrow Biologics Corp. (TSXV: MGRO, OTCQB: MGROF, FSE: 0C0) announced the outcomes of its 2024 annual shareholder meeting held on June 27, 2024. Shareholders voted to elect all director nominees listed in the management information circular dated May 28, 2024. The directors elected were Corey Giasson, Colin Bletsky, Brad Munro, Thomas Flow, Matt Kowalski, David Borecky, and Laura Westby, each receiving over 99.76% of the votes in favor.
Additionally, shareholders reappointed Ernst & Young LLP as the auditors and authorized the directors to determine their remuneration. The shareholders also reapproved the company's omnibus equity incentive plan, which is still subject to final TSX Venture Exchange approval. Detailed voting results will be available on SEDAR+.